{"product_id":"the-university-of-texas-md-anderson-cancer-center-iotox-symposium-treating-immune-related-adverse-events-integrating-insights-from-clinical-translational-and-basic-science-2024","title":"The University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch3\u003eThe University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e Include: 3 videos + 1 pdf, size: 8.4 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget Audience: allergy and immunology, internal medicine, and medical oncology, as well as pharmacists, physician associates, and trainees\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Wednesday, November 6, 2024, 12:00 PM – Thursday, November 7, 2024, 4:00 PM, TMC3 Collaborative Building, Houston, TX\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Allergy and Immunology, Internal Medicine, Medical Oncology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Nurse – APRN, Nurse – LVN, Nurse – RN, Other, Pharmacist, Physician (MD or DO), Physician Associate, Student or Trainee\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\n\u003cp\u003eThe IOTOX Symposium is designed to bring a diverse range of stakeholders together to foster collaboration, share cutting-edge research findings, and discuss treatment advancements in the field of immunotherapy toxicities. The Symposium will provide a platform for attendees to engage in in-depth discussions and attend presentations that highlight new methodologies, emerging technologies, and innovative clinical management strategies. By facilitating network and knowledge exchange, the Symposium seeks to drive scientific progress and translate research into practical treatment options to improve patient outcomes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCall for Abstracts\u003c\/strong\u003e\u003cbr\u003e\nWe invite faculty, trainees and staff to submit abstracts in the areas of clinical, translational, and basic science research. Submission deadline has been extended.\u003cstrong\u003e \u003c\/strong\u003eTo be considered for oral presentation, submit by Sunday, Sept. 29, 11:59pm.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this activity, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eConstruct the guideline recommendations for each toxicity.\u003c\/li\u003e\n\u003cli\u003eIdentify location and use of national societies guidelines for IOTOX.\u003c\/li\u003e\n\u003cli\u003eImplement IOTOX guidelines that are vetted by both oncologists and internal medicine specialists.\u003c\/li\u003e\n\u003cli\u003eIdentify patient treatment plans to evaluate difficult patient circumstances as it pertains to IOTOX.\u003c\/li\u003e\n\u003cli\u003eEmploy treatment plans and IOTOX guidelines to all providers including Pharmacists, APPs, Nurses and Trainees.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003cbr\u003e\nNovember 6 Part 1.mp4\u003cbr\u003e\nNovember 6 Part 2.mp4\u003cbr\u003e\nNovember 7.mp4\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDetail:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eWednesday, November 6, 2024\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRegistration and Check-In\u003c\/strong\u003e\u003cbr\u003e\n12:00PM – 1:00PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 1: Welcome and Keynote Address\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome Remarks\u003c\/strong\u003e\u003cbr\u003e\n1:00PM – 1:05PM\u003cbr\u003e\nDavid J. Tweardy, MDOverview \u0026amp; Introduction of Keynote Speaker\u003cbr\u003e\n(\u003cem\u003eNO CE Credit Awarded)\u003c\/em\u003e \n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKeynote Address: Reverse Translational Approaches to Drive Clinical Breakthroughs in Cancer Immunotherapy\u003c\/strong\u003e\u003cbr\u003e\n1:05PM – 1:50PM\u003cbr\u003e\nPadmanee Sharma, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n1:50PM – 2:00PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 2: Bedside to Bench: Integrating Clinical Practice and Translational Research in Immune-Mediated Colitis\u003c\/div\u003e\n\u003cp\u003eModerators: Adi Diab, MD; and Roza Nurieva, PhD\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClinical Management and Current Limitations in Treatment\u003c\/strong\u003e\u003cbr\u003e\n2:00PM – 2:30PM\u003cbr\u003e\nYinghong Wang, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClinical Trials and Translational Approaches to Solve Clinical Problems\u003c\/strong\u003e\u003cbr\u003e\n2:30PM – 3:00PM\u003cbr\u003e\nMichael Dougan, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eInterrogating the role of the IL-6\/IL-23-Th17 axis in Immune-Mediated Colitis\u003c\/strong\u003e\u003cbr\u003e\n3:00PM – 3:30PM\u003cbr\u003e\nAdi Diab, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePre-Clinical Models for Investigation of Immune-Mediated Colitis\u003c\/strong\u003e\u003cbr\u003e\n3:30PM – 4:00PM\u003cbr\u003e\nRoza Nurieva, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n4:00PM – 5:00PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBreak and Networking\u003c\/strong\u003e\u003cbr\u003e\n5:00PM – 5:15PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 3: Poster Presentations and Welcome Reception\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eSession 3: Poster Presentations and Welcome Reception\u003c\/strong\u003e\u003cbr\u003e\n5:15PM – 6:30PM\u003cem\u003e(No CE Credit Awarded)\u003c\/em\u003e \n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eThursday, November 7, 2024\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 4: Day 2 Welcome and Keynote Address\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWelcome Remarks\u003c\/strong\u003e\u003cbr\u003e\n8:00AM – 8:05AM\u003cbr\u003e\nChristopher R. Flowers, MD, FASCOOverview \u0026amp; Introduction of Keynote Speaker\u003cbr\u003e\n(\u003cem\u003eNO CE Credit Awarded)\u003c\/em\u003e \n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKeynote Address: Bridging Boundaries: National Efforts to Address Immunotherapy Toxicity\u003c\/strong\u003e\u003cbr\u003e\n8:05AM – 8:50AM\u003cbr\u003e\nPauline Funchain, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n8:50AM – 9:00AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 5: Round Table Discussions – Relevance of Mouse Models for Clinical Management of irAEs\u003c\/div\u003e\n\u003cp\u003eModerators: Adi Diab, MD; and Roza Nurieva, PhD\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanelists for Mouse Studies\u003c\/strong\u003e\u003cbr\u003e\n9:05AM – 9:10AM\u003cbr\u003e\nSeyed Javad M. Moghaddam, MD\u003cbr\u003e\nKristen Pauken, PhD\u003cstrong\u003ePanelists for Mouse Studies:\u003c\/strong\u003e\u003cbr\u003e\nKristen Pauken, PhD; and Seyed Moghaddam, MD \n\u003cp\u003e\u003cstrong\u003ePanelists for Human Studies:\u003c\/strong\u003e\u003cbr\u003e\nSumit Subudhi, MD; and Ala Abudayyeh, MD\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics to be Discussed:\u003cbr\u003e\n\u003c\/strong\u003e\u003cstrong\u003e• What is Heavily Conserved and Readily Modeled\u003cbr\u003e\n\u003c\/strong\u003e\u003cstrong\u003e• How to Translate These Findings Clinically\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePanelists for Human Studies\u003c\/strong\u003e\u003cbr\u003e\n9:10AM – 9:20AM\u003cbr\u003e\nSumit K Subudhi, MD, PhD\u003cbr\u003e\nAla Abudayyeh, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eBreak\u003c\/strong\u003e\u003cbr\u003e\n10:30AM – 10:40AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 6: Clinical Challenges and Research Directions in irAEs I\u003c\/div\u003e\n\u003cp\u003eModerators: Bilal A. Siddiqui, MD; and Sebastian T. Wurster MD\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eDermatologic irAEs\u003c\/strong\u003e\u003cbr\u003e\n10:40AM – 11:00AM\u003cbr\u003e\nNoah I Hornick, MD, PhD, FAAD\u003cbr\u003e\nSebastian T Wurster, MD (Moderator)\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n11:00AM – 11:10AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEndocrine irAEs\u003c\/strong\u003e\u003cbr\u003e\n11:10AM – 11:30AM\u003cbr\u003e\nNupur Kikani, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n11:30AM – 11:40AM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eRheumatologic irAEs\u003c\/strong\u003e\u003cbr\u003e\n11:40AM – 12:00PM\u003cbr\u003e\nAlexa Meara, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n12:00PM – 12:10PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eLunch\u003c\/strong\u003e\u003cbr\u003e\n12:10PM – 1:10PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 7: Clinical Challenges and Research Directions in irAEs II\u003c\/div\u003e\n\u003cp\u003eModerators: Yinghong (Mimi) Wang, MD, PhD; and Ashley Aaroe, MD\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eNeurologic irAEs\u003c\/strong\u003e\u003cbr\u003e\n1:10PM – 1:30PM\u003cbr\u003e\nBianca Santomasso, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n1:30PM – 1:40PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCardiac irAEs\u003c\/strong\u003e\u003cbr\u003e\n1:40PM – 2:00PM\u003cbr\u003e\nNicolas Palaskas, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n2:00PM – 2:10PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003ePulmonary irAEs\u003c\/strong\u003e\u003cbr\u003e\n2:10PM – 2:30PM\u003cbr\u003e\nAjay Sheshadri, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n2:30PM – 2:40PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eSession 8: Oral Abstract Presentations\u003c\/div\u003e\n\u003cp\u003eModerators: Arielle Raugh, PhD; and Synat Keam, PhD\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eReported Immunotherapy Toxicities on FDA Registration Trials for Solid Tumors – Is There More Than Meets the Eye?\u003c\/strong\u003e\u003cbr\u003e\n2:40PM – 2:50PM\u003cbr\u003e\nMatthew J Hadfield, DO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n2:50PM – 2:55PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eMechanistic Insights on Immune Checkpoint Inhibitor-Induced Recurrent Inflammatory Arthritis\u003c\/strong\u003e\u003cbr\u003e\n2:55PM – 3:05PM\u003cbr\u003e\nSynat Keam Sr., PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n3:05PM – 3:10PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eIntegrating Genetic and Radiographic Markers to Predict Immune Checkpoint Inhibitor Pneumonitis Risk in Non-Small Cell Lung Cancer\u003c\/strong\u003e\u003cbr\u003e\n3:10PM – 3:20PM\u003cbr\u003e\nFelipe Soto Lanza, MBBS,MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n3:20PM – 3:25PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eModeling Immune Checkpoint Inhibitor-Induced Colitis: Mechanistic Insights and Therapeutic Targets\u003c\/strong\u003e\u003cbr\u003e\n3:25PM – 3:35PM\u003cbr\u003e\nNaimah Turner, MS\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eQ\u0026amp;A Session\u003c\/strong\u003e\u003cbr\u003e\n3:35PM – 3:40PM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eClosing Remarks\u003c\/strong\u003e\u003cbr\u003e\n3:40PM – 3:45PM\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954576592994,"sku":"MED-AMB06467","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/PhotoFixerBot_20-22-27_UTC-scaled-1.jpg?v=1779380054","url":"https:\/\/meducourse.com\/products\/the-university-of-texas-md-anderson-cancer-center-iotox-symposium-treating-immune-related-adverse-events-integrating-insights-from-clinical-translational-and-basic-science-2024","provider":"Meducourse","version":"1.0","type":"link"}